• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma industry news

AstraZeneca Phase III breast cancer trial met primary endpoint

23 February 2017

AstraZeneca announced positive results from its Phase III trial comparing Lynparza to chemotherapy, to treat HER2-negative metastatic breast cancer...

First biosimilar mAb in oncology granted EU approval

23 February 2017

The European Commission has approved Truxima (biosimilar rituximab) for all indications of reference rituximab in the European Union (EU)...

Apitope’s Phase II multiple sclerosis trial a success

22 February 2017

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, announces positive results from the Phase IIa clinical study of its lead product candidate, ATX-MS-1467, for the treatment of patients with multiple sclerosis. The Phase IIa, open-label, one arm study evaluated the effects of ATX-MS-1467 in 19 patients with […]

New mid-infrared laser system could detect atmospheric chemicals

21 February 2017

Researchers at MIT have found a new way of using mid-infrared lasers to turn regions of molecules into glowing filaments of electrically charged gas...

Scientists developed a miniature gas sensor for mobile devices

21 February 2017

VTT Technical Research Centre of Finland has developed a miniature gas sensor that can be connected to mobile devices.

UPDATE: The Cancer Drugs Fund

21 February 2017

This page will be updated as the results from the Cancer Drugs Fund appraisal are announced by The National Institute of Health and Care Excellence (NICE).  Originally introduced in 2011, The Cancer Drugs Fund (CDF) was established by the coalition Government in order to provide a means by which NHS patients in England could get cancer […]

Paresthesias nerve problems linked to World Trade Centre toxic dust

21 February 2017

A new study has tied the World Trade Centre (WTC) site with paresthesias, a nerve-related issue causing burning or prickling sensations...

Sustainable development indicators – can statistical indicators transform from back mirrors into drivers of change?

20 February 2017

Johanna Laiho-Kauranne examines the 17 UN sustainable development goals that have been implemented for monitoring sustainability development...

Malaria control efforts can benefit from forecasting using satellites

20 February 2017

Umeå University researches have established links between patterns of malaria in Kenya and environmental factors measurable by satellite imagery...

Crohn’s disease

Celltrion Healthcare & Pfizer’s biosimilar shows positive results in Crohn’s disease study

20 February 2017

Celltrion Healthcare presented the primary outcome from its pivotal randomised controlled trial of CT-P13 (biosimilar infliximab) in Crohn’s disease.

FDA to review Mylan and Biocon’s biosimilar application

17 February 2017

The US Food and Drug Administration (FDA) has accepted Mylan and Biocon's biologics license application for MYL-1401H, a proposed biosimilar to Neulasta...

Suicidal ideation

FDA approves new psoriasis drug that induced suicide in trial

17 February 2017

The US Food and Drug Administration (FDA) has approved Valeant’s Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection. Siliq is intended for patients who are candidates for systemic therapy (treatment using substances that travel through the bloodstream, after being taken by mouth or injected) or phototherapy (ultraviolet light […]


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +